LQT Therapeutics

OverviewSuggest Edit

LQT Therapeutics is a life-science company. It aims to develop a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias.

TypePrivate
Founded2019
HQLaval, CA
Websitelqttrx.com

Locations

LQT Therapeutics is headquartered in
Laval, Canada

Location Map

Latest Updates

Employees (est.) (May 2020)6

LQT Therapeutics Office Locations

LQT Therapeutics has an office in Laval
Laval, CA (HQ)
500 Boulevard Cartier O
Show all (1)

LQT Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2019

LQT Therapeutics total Funding

$1.4 m

LQT Therapeutics latest funding size

$1.38 m

Time since last funding

5 months ago

LQT Therapeutics investors

LQT Therapeutics's latest funding round in January 2020 was reported to be $1.4 m. In total, LQT Therapeutics has raised $1.4 m
Show all financial metrics

LQT Therapeutics Online and Social Media Presence

Embed Graph

LQT Therapeutics Frequently Asked Questions

  • When was LQT Therapeutics founded?

    LQT Therapeutics was founded in 2019.

  • How many employees does LQT Therapeutics have?

    LQT Therapeutics has 6 employees.

  • Who are LQT Therapeutics competitors?

    Competitors of LQT Therapeutics include Fortress Biotech, BioCryst Pharmaceuticals and Zyla Life Sciences.

  • Where is LQT Therapeutics headquarters?

    LQT Therapeutics headquarters is located at 500 Boulevard Cartier O, Laval.

  • Where are LQT Therapeutics offices?

    LQT Therapeutics has an office in Laval.

  • How many offices does LQT Therapeutics have?

    LQT Therapeutics has 1 office.